Format

Send to

Choose Destination
Neuropsychopharmacology. 2019 Jan;44(1):231-232. doi: 10.1038/s41386-018-0205-7.

Motion mapping in humans as a biomarker for psychiatric disorders.

Author information

1
McLean Hospital, Belmont, MA, USA. ivahia@partners.org.
2
Harvard Medical School, Boston, MA, USA. ivahia@partners.org.
3
McLean Hospital, Belmont, MA, USA.
4
Harvard Medical School, Boston, MA, USA.
PMID:
30214060
PMCID:
PMC6235984
[Available on 2020-01-01]
DOI:
10.1038/s41386-018-0205-7
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center